265 related articles for article (PubMed ID: 33393670)
1. Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.
Ding ZN; Dong ZR; Chen ZQ; Yang YF; Yan LJ; Li HC; Liu KX; Yao CY; Yan YC; Yang CC; Li T
J Gastroenterol Hepatol; 2021 Jun; 36(6):1487-1496. PubMed ID: 33393670
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL
Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis.
Zheng SS; Chen XH; Yin X; Zhang BH
PLoS One; 2013; 8(6):e65753. PubMed ID: 23799043
[TBL] [Abstract][Full Text] [Related]
4. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
5. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
6. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis.
Lin X; Su H; Huo J; Zhang F
Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis.
Fan Y; Li H; Ma X; Gao Y; Chen L; Li X; Bao X; Du Q; Zhang Y; Zhang X
Medicine (Baltimore); 2015 Sep; 94(38):e1646. PubMed ID: 26402839
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis.
Chen Z; He X; Xia W; Huang Q; Zhang Z; Ye J; Ni C; Wu P; Wu D; Xu J; Qiu F; Huang J
PLoS One; 2013; 8(12):e80337. PubMed ID: 24324596
[TBL] [Abstract][Full Text] [Related]
10. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.
Menrad H; Werno C; Schmid T; Copanaki E; Deller T; Dehne N; Brüne B
Hepatology; 2010 Jun; 51(6):2183-92. PubMed ID: 20513003
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis.
Cao S; Yang S; Wu C; Wang Y; Jiang J; Lu Z
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):598-603. PubMed ID: 24835771
[TBL] [Abstract][Full Text] [Related]
13. HIF-2α attenuates lymphangiogenesis by up-regulating IGFBP1 in hepatocellular carcinoma.
Geis T; Popp R; Hu J; Fleming I; Henke N; Dehne N; Brüne B
Biol Cell; 2015 Jun; 107(6):175-88. PubMed ID: 25757011
[TBL] [Abstract][Full Text] [Related]
14. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis.
Rasheed S; Harris AL; Tekkis PP; Turley H; Silver A; McDonald PJ; Talbot IC; Glynne-Jones R; Northover JM; Guenther T
Br J Cancer; 2009 May; 100(10):1666-73. PubMed ID: 19436307
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.
Liang X; Zheng M; Jiang J; Zhu G; Yang J; Tang Y
Oral Oncol; 2011 Feb; 47(2):92-7. PubMed ID: 21167768
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.
Ahmad A; Ahmad S; Malcolm KC; Miller SM; Hendry-Hofer T; Schaack JB; White CW
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):78-85. PubMed ID: 23492195
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]